雷公藤多甙治疗风湿性疾病临床疗效分析

Analysis on therapy of 30 cases of rheumatic diseases by glycoside of Triptergiumipte wilfordii

目的：探讨雷公藤多甙（ＧＴＷ）对常规疗法疗效不佳的类风湿关节炎（ＲＡ）、系统性红斑 狼疮（ＳＬＥ）、干燥综合症（ＳＳ）及强直性脊椎炎（ＡＳ）的疗效。方法：选择３０例经常规治疗疗效不佳的患 者，改用雷公藤多甙治疗，进行疗效观察。结果：ＲＡ１６例，显效１０例，有效３例，无效２例；ＳＬＥ７例，显 效３例，有效３例，无效２例；ＳＬＥ７例，显效 ３例，有效３例，无效１例；ＳＳ１例，显效： ＡＳ６例，显效 ４ 例，有效２例。结论：即使经过常规治疗疗效不佳的患者，雷公藤多甙亦获得明显疗效。

Objective: To study the glycoside of tripterygium wilfordii(GTW)for those patients with RA(Rheumatoid Arthritis), SLE (System Lupus Erythematosus), SS(Sjogren's Syndrome) and AS(Ankylosiny Spondylitis)who were ineffective to the routine therapy. Method: Clinical observation was given on 30 patients who were given GTW after failed to the routine therapy.Result: RA 16 cases:predominantly effective 10 cases,effective 3 cases,ineffective 2 cases,SLE 7 cases: predominantly effective 3 cases,effective 3 cases,ineffective 1 case,SS 1 case:predominantly effective,AS 6 cases:predominantly effective 4 cases,effective 2 cases. Conclusion: GTW is effective even for those patients who failed to the routine therapy.